BR112017013027A2 - compostos à base de cumarina e métodos relacionados - Google Patents

compostos à base de cumarina e métodos relacionados

Info

Publication number
BR112017013027A2
BR112017013027A2 BR112017013027A BR112017013027A BR112017013027A2 BR 112017013027 A2 BR112017013027 A2 BR 112017013027A2 BR 112017013027 A BR112017013027 A BR 112017013027A BR 112017013027 A BR112017013027 A BR 112017013027A BR 112017013027 A2 BR112017013027 A2 BR 112017013027A2
Authority
BR
Brazil
Prior art keywords
coumarin
based compounds
related methods
alteration
undergoing
Prior art date
Application number
BR112017013027A
Other languages
English (en)
Inventor
De Jesus Sanchez Anthony
Original Assignee
Biosearch Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosearch Tech Inc filed Critical Biosearch Tech Inc
Publication of BR112017013027A2 publication Critical patent/BR112017013027A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/12—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical

Abstract

a presente invenção refere-se, de modo geral, a compostos à base de cumarina que podem ser usados para identificação de moléculas biológicas, assim como métodos sintéticos e de teste relacionados. os compostos à base de cumarina sobrevivem tipicamente a condições necessárias para a síntese automatizada de ácidos nucleicos sem passar por qualquer grau substancial de degradação ou alteração.
BR112017013027A 2015-01-20 2016-01-19 compostos à base de cumarina e métodos relacionados BR112017013027A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562125431P 2015-01-20 2015-01-20
PCT/US2016/000010 WO2016118305A1 (en) 2015-01-20 2016-01-19 Coumarin-based compounds and related methods

Publications (1)

Publication Number Publication Date
BR112017013027A2 true BR112017013027A2 (pt) 2018-01-09

Family

ID=56417579

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017013027A BR112017013027A2 (pt) 2015-01-20 2016-01-19 compostos à base de cumarina e métodos relacionados

Country Status (15)

Country Link
US (1) US11034677B2 (pt)
EP (1) EP3247710B1 (pt)
JP (2) JP6814139B2 (pt)
CN (1) CN107207480B (pt)
AU (1) AU2016209680B2 (pt)
BR (1) BR112017013027A2 (pt)
CA (1) CA2970353C (pt)
CL (1) CL2017001433A1 (pt)
DK (1) DK3247710T3 (pt)
ES (1) ES2931081T3 (pt)
MY (1) MY186450A (pt)
PL (1) PL3247710T3 (pt)
SG (1) SG11201705411SA (pt)
WO (1) WO2016118305A1 (pt)
ZA (1) ZA201704200B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108148574B (zh) * 2018-02-06 2020-06-16 中国刑事警察学院 可视化检验射击残留物的荧光探针及其制备方法和用途
US11834714B2 (en) 2021-12-20 2023-12-05 Enumerix, Inc. Detection and digital quantitation of multiple targets

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4775193A (en) 1992-07-17 1994-02-14 Aprogenex, Inc. In situ detection of nucleic acids using 3sr amplification
CN1084219A (zh) * 1992-07-17 1994-03-23 阿普罗精内斯有限公司 核酸的检测
US6495676B1 (en) 1993-04-13 2002-12-17 Naxcor Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
EP0827501A4 (en) 1995-03-09 1998-06-10 Naxcor NON-NUCLEOSIDIC CUMARINE DERIVATIVES AS A POLYNUCLEOTIDE CROSSLINKER
US6727356B1 (en) 1999-12-08 2004-04-27 Epoch Pharmaceuticals, Inc. Fluorescent quenching detection reagents and methods
DE10329860A1 (de) 2003-07-02 2005-01-20 Atto-Tec Gmbh Sulfonamidderivate polycyclischer Farbstoffe für analytische Anwendungen
US7705150B2 (en) * 2004-02-04 2010-04-27 Biosearch Technologies, Inc. Cyanine dyes
JP4713514B2 (ja) 2006-02-20 2011-06-29 エフ．ホフマン−ラ ロシュ アーゲー 改善された標識試薬
US20090156421A1 (en) * 2007-11-06 2009-06-18 Wyeth Assays and methods for evaluating multimeric complexes
US20090197254A1 (en) 2007-12-14 2009-08-06 Ming-Chou Lee Variant scorpion primers for nucleic acid amplification and detection
US20100029017A1 (en) * 2008-07-29 2010-02-04 Becton, Dickinson And Company Mono-chlorinated hydroxycoumarin conjugates
US20120016128A1 (en) 2010-07-16 2012-01-19 Zhenjun Diwu Rhodamine lactone phosphoramidites and polymers
FR3026698B1 (fr) * 2014-10-01 2018-05-04 U-Shin France Antivol pour colonne de direction de vehicule automobile

Also Published As

Publication number Publication date
US20170015652A1 (en) 2017-01-19
JP2018505141A (ja) 2018-02-22
EP3247710A1 (en) 2017-11-29
SG11201705411SA (en) 2017-08-30
PL3247710T3 (pl) 2023-03-06
CA2970353A1 (en) 2016-07-28
JP6814139B2 (ja) 2021-01-13
JP2021020903A (ja) 2021-02-18
DK3247710T3 (en) 2022-11-14
US11034677B2 (en) 2021-06-15
CA2970353C (en) 2021-07-06
AU2016209680A1 (en) 2017-06-08
EP3247710A4 (en) 2018-10-10
CN107207480B (zh) 2021-06-25
WO2016118305A1 (en) 2016-07-28
AU2016209680B2 (en) 2020-09-03
MY186450A (en) 2021-07-22
ES2931081T3 (es) 2022-12-23
CL2017001433A1 (es) 2017-12-15
ZA201704200B (en) 2021-10-27
CN107207480A (zh) 2017-09-26
EP3247710B1 (en) 2022-10-19

Similar Documents

Publication Publication Date Title
BR112019006106A2 (pt) formulação carregada com canabinoide, processo para preparar a formulação carregada com canabinoide, composições farmacêutica e nutracêutica, e, método de tratamento de um indivíduo sofrendo de uma enfermidade ou um distúrbio.
BR112017020893A2 (pt) método para o tratamento de câncer
BR112017017025A2 (pt) métodos e composições para analizar componentes celulares
BR112017018008A2 (pt) ?métodos de prognóstico e/ou diagnóstico do câncer, para determinação da dosagem de um produto, para adaptar a dosagem de um produto, para determinar os efeitos benéficos e/ou adversos de uma substância, para identificar um paciente como respondedor a um tratamento, para identificar um paciente como não respondedor a um tratamento, para tratar o câncer, meios para prognosticar e/ou diagnosticar, kit, uso dos meios e dispositivo para a identificação de câncer?
UY36705A (es) Compuestos de 4-hidroxi-3-(heteroaril)piridin-2-ona como agonistas de apj
BR112016029583A2 (pt) ?kit ou dispositivo para a detecção de câncer esofágico e método de detecção?
UY36175A (es) 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas
BR112016029521A2 (pt) ?kit, dispositivo e método para a detecção de câncer de estômago?
BR112018011709A2 (pt) inibidores bicíclicos de pad4
EA201692157A1 (ru) Синтез двухцепочечных нуклеиновых кислот
PE20160192A1 (es) Composiciones y metodo para tratar condiciones asociadas con el complemento
CO2018005393A2 (es) Anticuerpos anti-htra1 y métodos de uso de los mismos
BR112018017168A2 (pt) emplastro de coloração do sangue, método e dispositivo para teste sanguíneo usando o mesmo
BR112017010311A2 (pt) 4-oxo-3,4-dihidro-1,2,3-benzotriazinas como moduladores de gpr139
BR112018014590A2 (pt) formulações/composições compreendendo um inibidor de btk
UY36223A (es) Dispositivos para ensayos, métodos para realizar ensayos, kits para ensayos y método para fabricar dispositivos para ensayos
BR112018069303A2 (pt) método para tratamento de uma infecção
FR3038827B1 (fr) Ensemble d’instrumentation chirurgicale
FR3031641B1 (fr) Procede d'identification d'une entite
BR112017019841A2 (pt) técnica de análise de amostra de tecido
FR3043811B1 (fr) Procede d'identification d'une entite
BR112016002668A2 (pt) métodos e kits para prognosticar o risco de ter uma doença ou evento cardiovasculares
BR112018003800A2 (pt) derivados de 1,7-diaril-1,6-heptadieno-3,5-diona, processo para a sua produção e utilização
BR112018013269A2 (pt) composições e métodos para a avaliação do risco de ocorrência do câncer
BR112016000231A8 (pt) métodos para identificações de condições de separação com cromatografia de troca de íons e para análises de composições de polipeptídeos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI 2506 DE 15/01/2019